Insufficient scRNA-seq data for expression of SETD1A at single-cell level.
Insufficient scRNA-seq data for expression of SETD1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3059.10 | 258 / 258 | 100% | 22.61 | 230 / 230 |
esophagus | 100% | 3177.11 | 1445 / 1445 | 100% | 41.58 | 183 / 183 |
thymus | 100% | 4078.47 | 653 / 653 | 100% | 26.40 | 605 / 605 |
uterus | 100% | 4361.43 | 170 / 170 | 100% | 28.76 | 459 / 459 |
skin | 100% | 3346.40 | 1809 / 1809 | 100% | 32.69 | 471 / 472 |
ovary | 100% | 3783.90 | 180 / 180 | 100% | 35.71 | 429 / 430 |
prostate | 100% | 3476.93 | 245 / 245 | 100% | 22.62 | 500 / 502 |
intestine | 100% | 3524.67 | 966 / 966 | 99% | 25.83 | 524 / 527 |
breast | 100% | 3399.05 | 459 / 459 | 99% | 27.95 | 1108 / 1118 |
stomach | 100% | 2584.05 | 359 / 359 | 99% | 28.91 | 283 / 286 |
pancreas | 100% | 1893.94 | 328 / 328 | 99% | 21.28 | 176 / 178 |
kidney | 100% | 2415.82 | 89 / 89 | 99% | 20.57 | 889 / 901 |
lung | 100% | 2761.00 | 578 / 578 | 98% | 25.13 | 1137 / 1155 |
brain | 99% | 2113.89 | 2609 / 2642 | 100% | 28.13 | 702 / 705 |
bladder | 100% | 3259.90 | 21 / 21 | 98% | 23.99 | 495 / 504 |
liver | 100% | 1730.61 | 226 / 226 | 96% | 14.11 | 390 / 406 |
adipose | 100% | 3177.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2959.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 28.83 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.77 | 29 / 29 |
muscle | 100% | 2777.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3764.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 21.01 | 1 / 1 |
heart | 99% | 1590.54 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 1271.26 | 708 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032259 | Biological process | methylation |
GO_1902275 | Biological process | regulation of chromatin organization |
GO_0006974 | Biological process | DNA damage response |
GO_0006338 | Biological process | chromatin remodeling |
GO_1902036 | Biological process | regulation of hematopoietic stem cell differentiation |
GO_0007420 | Biological process | brain development |
GO_0035097 | Cellular component | histone methyltransferase complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0048188 | Cellular component | Set1C/COMPASS complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042800 | Molecular function | histone H3K4 methyltransferase activity |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0003723 | Molecular function | RNA binding |
GO_0140999 | Molecular function | histone H3K4 trimethyltransferase activity |
GO_0140945 | Molecular function | histone H3K4 monomethyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SETD1A |
Protein name | SET domain containing 1A, histone lysine methyltransferase Alternative protein SETD1A Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.364) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1) |
Synonyms | KMT2F KIAA0339 SET1 SET1A |
Description | FUNCTION: Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism . Part of chromatin remodeling machinery, forms H3K4me1, H3K4me2 and H3K4me3 methylation marks at active chromatin sites where transcription and DNA repair take place . Responsible for H3K4me3 enriched promoters and transcriptional programming of inner mass stem cells and neuron progenitors during embryogenesis (By similarity) . Required for H3K4me1 mark at stalled replication forks. Mediates FANCD2-dependent nucleosome remodeling and RAD51 nucleofilaments stabilization at reversed forks, protecting them from nucleolytic degradation . Does not methylate 'Lys-4' of histone H3 if the neighboring 'Lys-9' residue is already methylated . Binds RNAs involved in RNA processing and the DNA damage response . . |
Accessions | C9J2Z9 ENST00000452917.3 ENST00000684162.1 ENST00000262519.14 O15047 ENST00000710314.1 L0R6N9 |